S.2516 - Food and Drug Administration Safety and Innovation Act

An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

One Moment Please

Flat-loader
Loading Bill Text

Rollover any line of text to comment and/or link to it.